<DOC>
	<DOCNO>NCT01552941</DOCNO>
	<brief_summary>This 12 week open label pilot study determine efficacy safety surgically implant , electrically active vagal nerve stimulation device patient active rheumatoid arthritis .</brief_summary>
	<brief_title>Safety Efficacy Vagal Nerve Stimulation Patients With Rheumatoid Arthritis</brief_title>
	<detailed_description />
	<mesh_term>Arthritis</mesh_term>
	<mesh_term>Arthritis , Rheumatoid</mesh_term>
	<criteria>Adultonset rheumatoid arthritis least six month duration define 2010 ACR/EULAR classification criterion ( Aletaha , 2010 ) Male female patient , 1875 year age , inclusive Functional status I , II , III classify accord ACR 1991 revise criterion ( Hochberg , 1992 ) Patients must active disease define least 4 active tender swollen joint CRP 0.7 mg/dL , despite least 3 month treatment methotrexate dose 25 mg orally per week . Patients may previously treat TNF antagonist , must fail reason inadequate safety , intolerance side effect , development antibody ( i.e. , secondary failure ) , specifically fail basis primary lack efficacy Study amend add second cohort 10 patient fail TNF antagonist least one biological therapy nonTNF antagonist mechanism action History unilateral bilateral vagotomy History recurrent vasovagal syncope episodes Known obstructive sleep apnea Known history cardiac rhythm disturbance , atrioventricular block great first degree , cardiac conduction pathway abnormality isolate right bundle branch block isolate leave anterior fascicle block Significant pharyngeal dysfunction swallow difficulty Preexisting clinically significant vocal cord damage hoarseness Previously implant electrically active medical device ( e.g. , cardiac pacemaker , automatic implantable cardioverterdefibrillators ) Asthma chronic obstructive pulmonary disease control medication , disease cause clinically significant dyspnea time screen Active peptic ulcer disease</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>October 2016</verification_date>
	<keyword>Vagus Nerve</keyword>
	<keyword>Vagal Nerve Stimulation</keyword>
	<keyword>Rheumatoid Arthritis</keyword>
	<keyword>Implantable Medical Device</keyword>
</DOC>